💰 Dividend History

No dividend history available.

📅 Earnings & EPS History for PELI

No earnings history available for this symbol.

📰 Related News & Research

• Alto Neuroscience Announces Phase 2 Results for ALTO-101, Prioritizes ALTO-207 in Treatment-Resistant Depression Pipeline 123
  April 2, 2026
  

  Alto Neuroscience Reports Phase 2 Data and Pipeline Update ...

• TuHURA Biosciences Reports 2025 Financial Results, Advances Phase 3 Cancer Trials and Expands Pipeline with VISTA Antibody Acquisition
  April 1, 2026
  

  TuHURA Biosciences Reports Q4 and Full Year 2025 Results, Pr...

• Liminatus Pharma 2025 Annual Report: Pre-Clinical Cancer Therapy Pipeline, Strategy, and Risk Overview
  April 1, 2026
  

  Liminatus Pharma, Inc. 2025 Annual Report: Key Highlights fo...

• Artificial Intelligence Technology Solutions (AITX) and RAD Advance Global Expansion and Sales Pipeline After Strong ISC West 2026 Performance
  March 31, 2026
  

  AITX's RAD Hosts First Global Sales Conference – Key Investm...

• ImmunityBio Secures $100 Million Financing to Accelerate Global Expansion and Advance ANKTIVA Immunotherapy Pipeline
  March 31, 2026
  

  ImmunityBio Secures \$100M Financing and Marks Global Expans...

• Elauwit Connection Reports 154% Revenue Growth for 2025, Driven by Recurring Service and Expanding Sales Pipeline
  March 31, 2026
  

  Elauwit Connection, Inc. Reports 154% Revenue Growth, Launch...

• Cocrystal Pharma Reports 2025 Financial Results and Advances Norovirus and Influenza Antiviral Drug Pipeline
  March 31, 2026
  

  Cocrystal Pharma 2025 Financial Results and Pipeline Update:...

• OS Therapies Inc: Advancing Osteosarcoma Treatment with OST-HER2 Immunotherapy and Next-Generation Oncology Pipeline
  March 31, 2026
  

  OS Therapies Inc (OSTX) 2025 Annual Report – Key Investor Hi...

• NeOnc Technologies: Innovative Drug Delivery Platforms and Pipeline for Brain Cancer and CNS Disorders
  March 31, 2026
  

  NeOnc Technologies Holdings, Inc. (NTHI) 2025 Annual Report ...

• IMUNON, INC. 2025 Annual Report: Pipeline, Clinical Trials, Financials & Business Strategy Overview
  March 31, 2026
  

  IMUNON, INC. 2025 Annual Report – Key Highlights for Investo...

🔍 View more Reports